Aryl hydrocarbon receptor nuclear translocator (ARNT) isoforms control lymphoid cancer cell proliferation through differentially regulating tumor suppressor p53 activity-Reference-Cited by-同舟云学术

Aryl hydrocarbon receptor nuclear translocator (ARNT) isoforms control lymphoid cancer cell proliferation through differentially regulating tumor suppressor p53 activity

Published:2016-02-20 Issue:10 Volume:7 Page:10710-10722
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Gardella Kacie A.¹,Muro Israel²,Fang Gloria²,Sarkar Krishnakali¹,Mendez Omayra¹,Wright Casey W.²¹

Affiliation:

1. Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, TX, USA

2. Division of Pharmacology and Toxicology, and the Center for Molecular and Cellular Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting ARNT attenuates chemoresistance through destabilizing p38α-MAPK signaling in glioblastoma;Cell Death & Disease;2024-05-28

2. A comprehensive functional investigation of the human translocator protein 18 kDa (TSPO) in a novel human neuronal cell knockout model: from molecule to depression;2024-03-13

3. Targeting ARNT attenuates Chemoresistance Through Destabilizing p38α-MAPK Signaling in Glioblastoma;2024-01-23

4. The complex biology of aryl hydrocarbon receptor activation in cancer and beyond;Biochemical Pharmacology;2023-10

5. Induction of Aryl Hydrocarbon Receptor-Mediated Cancer Cell-Selective Apoptosis in Triple-Negative Breast Cancer Cells by a High-Affinity Benzimidazoisoquinoline;ACS Pharmacology & Translational Science;2023-06-07